Hims & Hers Health, Inc. (HIMS) Lags Q4 Earnings Estimates

Company Performance - Hims & Hers Health, Inc. reported quarterly earnings of $0.11 per share, missing the Zacks Consensus Estimate of$0.12 per share, but showing an increase from earnings of $0.01 per share a year ago, representing an earnings surprise of -8.33$481.14 million for the quarter ended December 2024, surpassing the Zacks Consensus Estimate by 2.06%, and showing significant growth from year-ago revenues of 246.62 million [2] - Over the last four quarters, Hims & Hers Health has surpassed consensus EPS estimates two times and topped consensus revenue estimates four times [2] Stock Performance - Hims & Hers Health shares have increased approximately 103.8% since the beginning of the year, significantly outperforming the S&P 500's gain of 2.2% [3] - The current consensus EPS estimate for the coming quarter is 0.14 on revenues of $497.8 million, and for the current fiscal year, it is$0.55 on revenues of $2.07 billion [7] Industry Outlook - The Medical Info Systems industry, to which Hims & Hers Health belongs, is currently ranked in the top 36% of over 250 Zacks industries, indicating a favorable outlook [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact stock performance [5]